Sažetak
Uvod/Cilj. Infekcije urinarnog trakta jedne su od najčešće prisutnih infekcija u vanbolničkoj praksi. Cilj ovog istraživanja bio je da se identifikuju uzročnici infekcija urinarnog trakta i stepen njihove rezistencije na antimikrobne lekove u urbanom području centralne Srbije, kao i njihova povezanost sa starošću i polom bolesnika. Metode. Studija je bila sprovedena kao retrospektivna analiza podataka prikupljenih tokom rutinskog rada na obradi urinokultura vanbolničkih pacijenata sa simptomatskom infekcijom urinarnog trakta u periodu od januara 2009. do decembra 2013. godine. Rezultati. Ukupno je bilo analizirano 71 905 kultura, od kojih je 24 713 (34,37%) bilo pozitivno na prisustvo bakterijskih patogena. Najčešće izolovani uzročnik urinarnih infekcija bila je Escherichia coli (E. coli) (56,56%), zatim vrste Klebsiella (16,20%), Proteus (14,68%), Enterococcus (5,29%) odnosno Pseudomonas aeruginosa (3,74%). E. coli i Enterococcus izolati bili su manje zastupljeni kod muškaraca starosti ≥ 60 godina (23,71%, odnosno 4,87%), dok su uzročnici Klebsiella vrsta preovladavali u toj starosnoj grupi (32,06%). Najčešće izolovani uzročnici kod osoba muškog pola starosti 15–29 godina bili su pripadnici vrsta Enterococcus i Pseudomonas aeruginosa (13,28% svaki). Među ženama, učestalost izolacije E. coli bila je visoka u svim starosnim grupama (oko 70%). Proteus vrste često su bile izolovane kod pripadnica ženskog pola starosti do 14 godina (13,27%), dok je Klebsiella bila najčešće zastupljena u najstarijoj grupi žena (10,99%). Zaključak. Izbor antibiotske terapije za urinarne infekcije treba da bude baziran na lokalnim obrascima rezistencije i usklađen sa polom i životnim dobom bolesnika.Ključne reči
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Array
Reference
Gonzalez CM, Schaeffer AJ. Treatment of urinary tract infection: What's old, what's new, and what works. World J Urol 1999; 17(6): 372−82.
Litwin MS, Saigal CS. Urologic Diseases in America. US, Washington, DC: Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, U.S. Government Publishing Office; 2012.
Institute of Public Health of Serbia “Dr Milan Jovanovic Ba-tut”. Health Statistical Yearbook of Republic of Serbia 2012. Belgrade: Elit medica; 2012.
Hooton TM. Clinical practice. Uncomplicated urinary tract in-fection. N Engl J Med 2012; 366(11): 1028−37.
Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. Com-munity-onset urinary tract infections: A population-based as-sessment. Infection. 2007; 35(3): 150−3.
Foxman B. Urinary tract infection syndromes: Occurrence, re-currence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 2014; 28(1): 1−13.
Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. Eur J Obstet Gynecol Re-prod Biol 2011; 156(2): 131−6.
Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Pickard RS, et al. Guidelines on Urological Infections. Arnhem, The Netherlands: European Association of Urology (EAU); 2013.
Alós JI. Epidemiology and etiology of urinary tract infections in the community. Antimicrobial susceptibility of the main pathogens and clinical significance of resistance. Enferm In-fecc Microbiol Clin 2005; 23(Suppl 4): 3−8.
Mačužić B, Vujić A, Janković S. Antibiotic resistance is the cause of urinary tract infections in children. Med J (Krag) 2013; 47(4): 185−91. (Serbian)
Uzunovic-Kamberovic S. Antibiotic resistance of coliform organ-isms from community-acquired urinary tract infections in Zen-ica-Doboj Canton, Bosnia and Herzegovina. J Antimicrob Chemother 2006; 58(2): 344−8.
Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Wayne, Penn-sylvania: Clinical and Laboratory Standards Institute; 2010.
Francesco MA, Ravizzola G, Peroni L, Negrini R, Manca N. Urinary tract infections in Brescia, Italy: Etiology of uropathogens and antimicrobial resitance of common uropathogens. Med Sci Monit 2007; 13(6): BR136−44.
Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A. Urinary tract infections caused by multi-drug resistant Proteus mirabilis: Risk factors and clinical outcomes. Infection 2010; 38(1): 41−6.
Rahman F, Chowdhury S, Rahman MM, Ahmed D, Hossain A. An-timicrobial resistance pattern of gram-negative bacteria causing urinary tract infection. S J Phar Sci 2009; 2(1): 44−50.
Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol 2007; 33(1): 42−8; discussion 49.
Tabibian JH, Gornbein J, Heidari A, Dien SL, Lau VH, Chahal P, et al. Uropathogens and host characteristics. J Clin Microbiol 2008; 46(12): 3980−6.
Koeijers JJ, Verbon A, Kessels AG, Bartelds A, Donkers G, Nys S, et al. Urinary tract infection in male general practice patients: uropathogens and antibiotic susceptibility. Urology 2010; 76(2): 336−40.
Nimri L. Community-acquired urinary tract infections in a rural area in Jordan: Predominant uropathogens, and their anti-microbial resistance. Webmed Central Microbiol 2010; 1: 1−10.
Magliano E, Grazioli V, Deflorio L, Leuci AI, Mattina R, Romano P, et al. Gender and age-dependent etiology of community-acquired urinary tract infections. Sci World J 2012; 2012: 349597.
Linhares I, Raposo T, Rodrigues A, Almeida A. Frequency and an-timicrobial resistance patterns of bacteria implicated in com-munity urinary tract infections: A ten-year surveillance study. BMC Infect Dis 2013; 13: 19.
Lo DS, Shieh HH, Ragazzi SL, Koch VH, Martinez MB, Gilio AE. Community-acquired urinary tract infection: Age and gender-dependent etiology. J Bras Nefrol 2013; 35(2): 93−8.
Jaquiery A, Stylianopoulos A, Hogg G, Grover S. Vulvovaginitis: Clinical features, aetiology, and microbiology of the genital tract. Arch Dis Child 1999; 81(1): 64−7.
Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Voss A. Society's failure to protect a precious resource: Antibiotics. Lancet 2011; 378(9788): 369−71.
Mazzulli T. Resistance trends in urinary tract pathogens and impact on management. J Urol 2002; 168(4 Pt 2): 1720−2.
European Association of Urology (EAU). UT – lower urinary tract infections in females. Uppsala, Sweden: The Medical Products Agency; 2007.
Guneysel O, Onur O, Erdede M, Denizbasi A. Trime-thoprim/sulfamethoxazole resistance in urinary tract infec-tions. J Emerg Med 2009; 36(4): 338−41.
Farrell DJ, Morrissey I, De RD, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46(2): 94−100.
Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Esche-richia coli from community-acquired urinary tract infections in Europe: The ECO•SENS study revisited. Int J Antimicrob Agents 2012; 39(1): 45−51.
Bean DC, Krahe D, Wareham DW. Antimicrobial resistance in community and nosocomial Escherichia coli urinary tract iso-lates, London 2005-2006. Ann Clin Microbiol Antimicrob 2008; 7: 13.
Gyssens IC. Antibiotic policy. Int J Antimicrob Agents 2011; 38(Suppl): 11−20.
Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: An international survey on the antimicro-bial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34(5): 407−13.